Document is current
Any future updates will be listed below
-
Authors
Henkel, Pia S. https://orcid.org/0009-0009-8252-6754
Pedersen, Kine
Taskén, Kjetil
Hult, Ebba Hallersjö
Gelderblom, Hans
Fagereng, G. Live
Landsverk, Helga B.
Aas, Eline
,
-
Funding
Funding for this research was provided by:
University of Oslo
- License Information
-
More Information
Article History
Received: 5 January 2026
Accepted: 20 March 2026
First Online: 2 April 2026
Declarations
:
: KT and GLF are part of the Trial Management Committee for the IMPRESS-Norway trial that, through contracts with Oslo University Hospital, has research collaborations with Roche Foundation Medicine and Illumina on comprehensive genomic profiling and use of circulating tumor DNA. The other authors declare no competing interest with regards to the content of this work.
: The collection of data trough expert interviews was approved by the Norwegian Agency for Shared Services in Education and Research (SIKT) (reference nr. 371455). Written informed consent was obtained from the interviewees. No ethical approval required for survey and literature search.
